4DMEDICAL Ltd (4DX)
20mins delayed
Movement
1 Year Return
4DMEDICAL Ltd Chart
Share price | |
Last | |
Change | |
Volume | |
Turnover | |
Market Cap | $397.4 million |
Today's Movement | |
Prev. Close | |
Open | |
Day Range | - |
VWAP |
Historical Stats | |
52w Range | - |
4w Avg Volume | |
4w Avg Turnover | |
(delayed) |
4DX Statistics
22 January
487 / 2,255
ASX Size Rank
1yr Return
vs Sector (1yr)
+29.25%
vs ASX 200 (1yr)
+44.94%
$397.4 million
Market Cap
Share Issue
177.41 million
All Ords (%)
N/A
Short Sold
0.01%
Current Fundamentals
22 January
N/A
PE Ratio
EPS ($)
-
Earnings Yield
-
NTA ($)
-
0.00%
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
4DMedical Limited (4DX) is a Melbourne-based software technology company commercialising its patented imaging platform, 'XV Technology'. This four-dimensional lung imaging technology utilises proven, patented mathematic models and algorithms to convert X-ray scans into quantitative data to enhance the capacity of physicians to manage patients with respiratory diseases and diseases of the lung.

Upcoming Calendar
27 Aug 2021 | Report (Prelim) |
23 Sep 2021 | Report (Annual) |
Dividend History
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
No dividends paid in the last 5 years |
See Upcoming Dividends for all ASX companies.
Announcements
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Announcements provided by

Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
4DX is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
Director Transactions
4DX directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
There are no director transactions for code 4DX in our database.
Shareholder Distribution
Shareholder Distribution data is unavailable.
Top 20 Shareholders
Name | Shares | Capital |
---|---|---|
Velocimetry Consulting Pty Ltd (Fouras Family A/C) | 64,838,000 | 24.49% |
HSBC Custody Nominees (Australia) Limited (i) | 10,136,428 | 3.83% |
National Nominees Limited | 9,076,064 | 3.43% |
Pacific Custodins Pty Limited (Employee Share TST A/C) | 7,677,919 | 2.90% |
Ryder Innovation Fund Lp | 6,290,475 | 2.38% |
Mainstream Fund Services Pty Ltd | 5,766,269 | 2.18% |
CS Third Nominees Pty Limited (HSBC Cust Nom Au Ltd 13 A/C) | 5,239,727 | 1.98% |
SSD Nominees Pty Ltd (SSD Family A/C) | 5,000,000 | 1.89% |
Jordan Blair Thurgood & Phillip Charles Thurgood | 5,000,000 | 1.89% |
J P Morgan Nominees Australia Pty Limited | 4,816,959 | 1.82% |
BNP Paribas Noms Pty Ltd (DRP) (i) | 3,934,191 | 1.49% |
Citicorp Nominees Pty Limited | 2,653,144 | 1.00% |
Alex Petrou & Christine Petrou (Petrou Family Super Fund A/C) | 2,462,000 | 0.93% |
HSBC Custody Nominees Australia) Limited - A/C 2 (iii) | 2,157,535 | 0.81% |
Endless Smiles Pty Ltd (CMBK Family A/C) | 2,100,000 | 0.79% |
Dean Egan | 1,904,500 | 0.72% |
BNP Paribas Noms Pty Ltd (DRP) (ii) | 1,572,619 | 0.59% |
HSBC Custody Nominees Australia) Limited-Gsco Eca (ii) | 1,506,850 | 0.57% |
Merrill Lynch (Australia) Nominees Pty Ltd | 1,467,778 | 0.55% |
Morgan Stanley Australia Securities (Nominee) Pty Limited (No 1 Account) | 1,369,864 | 0.52% |
All other shareholders | 45.24 % |
The Top 20 Shareholders of 4DX hold 54.76% of shares on issue.
4DX Share Price History
Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
4DX Historical Data
Download up to 20 years of share price history.
Year | Closing Price (30 June) | Last Trade |
---|
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Medical imaging software and hardware provider.
Incorporated: --
Suite 501, Level 5, 468 St Kilda Rd
Melbourne VIC 3004

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.